Radleys

ChemBridge

16981 Via Tazon,

Suite G,

San Diego,

CA 92127
United States of America

Tel: 858 451 7400
Fax: 858 451 7401

Print Email to a friend

ChemBridge Corporation is the premiere provider of small molecule libraries for lead generation. An expansive array of 450,000 drug-like small molecules can be obtained from ChemBridge’s various collections. ChemBridge provides a diverse, 100,000 combinatorial compound library(PHARMACophore®)as well as internally designed focused libraries (i.e.GPCR & Kinase). ChemBridge has developed major collaborations with top pharmaceutical companies including its strategic alliance with Pfizer, which involves over 100 ChemBridge and CRL scientists worldwide. In addition, ChemBridge possess the industry’s largest proprietary building block collection, PHARMABlocks®.

CRL (ChemBridge Research Laboratories) is an independent company, spun-off from ChemBridge, focusing on sophisticated custom libraries, various hit-to-lead and lead optimization projects, as well as collaborative drug discovery projects. Altogether, ChemBridge Group (ChemBridge/CRL) constitutes the world’s largest global discovery chemistry out-sourcing resource base with over 400 employees and 300+ clients worldwide.

Further Information: http://www.chembridge.com/



Related news from our archive

ChemBridge Corporation and CRL Announces Collaboration with AstraZeneca
Scientists will work together to develop small molecule libraries enhancing AstraZeneca's global drug discovery effort.

ChemBridge Corporation and CRL Announces Collaboration with AstraZeneca
Scientists will work together to develop small molecule libraries enhancing AstraZeneca's global drug discovery effort.

ChemBridge Research Laboratories names Executive Director of Chemistry and expands MedChem

ChemBridge and ChemBridge Research Laboratories (CRL) announce a strategic multi-year discovery chemistry collaboration with Pfizer

CRL Announces Success in GPCR-Targeted Library Tests

ChemBridge and Eisai collaboration